Abbott launches 14-valent pneumococcal vaccine in India for children

Quick Summary:

Don't miss the most important news and views of the day.

The recommended immunisation schedule for PneumoShield 14, administered via intramuscular injections, is at six, ten, and fourteen weeks.

The company declined to comment on queries regarding discussions with the government to include PneumoShield 14 in the immunisation programmes.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Abbott India 14-valent pneumococcal vaccine PCV 10 PneumoShield 14 Swati Dalal Pneumococcal serotypes Government immunisation programmes Vaccine innovation Universal immunisation programme PCV 13 PCV launch in India Paediatric vaccines Invasive pneumococcal disease Childhood mortality Pneumococcal immunisation IPD mortality

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-27 @ 18:44:40 (5 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 286 words

Reading Time: 2 minutes read

Sentences: 12 lines

Sentence Length: 24 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 23906161

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 298 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions